HuGE Literature Finder
Records
1
-
3
PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential. European journal of cancer (Oxford, England : 1990) 2016 Jul 65 80-90. Wartenberg Martin, Centeno Irene, Haemmig Stefan, Vassella Erik, Zlobec Inti, Galván José A, Neuenschwander Maja, Schlup Cornelia, Gloor Beat, Lugli Alessandro, Perren Aurel, Karamitopoulou E |
Diagnostic yield of targeted next generation sequencing in various cancer types: an information-theoretic approach. Cancer genetics 2015 Sep 208 (9): 441-7. Hagemann Ian S, O'Neill Patrick K, Erill Ivan, Pfeifer John |
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. British journal of cancer 2012 Nov . Boeck S, Jung A, Laubender RP, Neumann J, Egg R, Goritschan C, Vehling-Kaiser U, Winkelmann C, Fischer von Weikersthal L, Clemens MR, Gauler TC, Märten A, Klein S, Kojouharoff G, Barner M, Geissler M, Greten TF, Mansmann U, Kirchner T, Heinemann V |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: